When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
VIRI - Virios Therapeutics Long-COVID trial begins dosing
Virios Therapeutics Inc.
Virios Therapeutics ( NASDAQ: VIRI ) said enrollment in an exploratory Long-COVID trial began and the first patient was dosed.
The study is supported via an investigational grant to the Bateman Horne Center, the company noted in an Aug. 15 press release.
The company said the study will evaluate antiviral therapy with Virios' second development combination, IMC-2 (valacyclovir + celecoxib), to treat the symptoms linked with Long-COVID, including fatigue, pain, sleep disruption, anxiety, depression and cognitive function.